CORCEPT THERAPEUTICS INC Increase (Decrease) in Accounts Receivable
CORCEPT THERAPEUTICS INC (CORT) reported Increase (Decrease) in Accounts Receivable of $17.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $37.85M, a 1277.29% increase year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$20.71M, a 364.11% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$9.84M.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $5.06M, a 13.91% decline year-over-year.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts receivable for fiscal 2025 was $5.81M, a 54.80% decline from fiscal 2024.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts receivable for fiscal 2024 was $12.85M, a 27.69% increase from fiscal 2023.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts receivable for fiscal 2023 was $10.07M, a 193.30% increase from fiscal 2022.
- CORCEPT THERAPEUTICS INC increase (decrease) in accounts receivable for fiscal 2022 was $3.43M, a 140.50% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $37.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $17.13M 10-Q · filed 2026-07-29 | $7.29M derived: sum of 3 quarters · filed 2026-07-29 | $12.35M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$20.71M 10-Q · filed 2026-04-30 | -$30.56M derived: sum of 2 quarters · filed 2026-04-30 | -$25.50M derived: sum of 3 quarters · filed 2026-04-30 | -$22.75M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$9.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$4.78M derived: sum of 2 quarters · filed 2026-02-24 | -$2.03M derived: sum of 3 quarters · filed 2026-07-29 | $5.81M 10-K · filed 2026-02-24 |
| 2025-09-30 | $5.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.81M derived: sum of 2 quarters · filed 2026-07-29 | $15.65M 10-Q · filed 2025-11-04 | $9.91M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $10.59M 10-Q · filed 2026-07-29 | $4.85M derived: sum of 3 quarters · filed 2026-07-29 | $10.73M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $7.84M 10-Q · filed 2026-04-30 | $2.10M derived: sum of 2 quarters · filed 2026-04-30 | $7.98M derived: sum of 3 quarters · filed 2026-04-30 | $301.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $139.00K derived: sum of 2 quarters · filed 2026-02-24 | -$7.54M derived: sum of 3 quarters · filed 2026-02-24 | $12.85M 10-K · filed 2026-02-24 |
| 2024-09-30 | $5.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.80M derived: sum of 2 quarters · filed 2025-11-04 | $18.59M 10-Q · filed 2025-11-04 | $25.09M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$7.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $12.71M 10-Q · filed 2025-07-31 | $19.21M derived: sum of 3 quarters · filed 2026-02-24 | $21.28M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $20.39M 10-Q · filed 2025-05-05 | $26.89M derived: sum of 2 quarters · filed 2026-02-24 | $28.96M derived: sum of 3 quarters · filed 2026-02-24 | $28.96M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $8.57M derived: sum of 2 quarters · filed 2026-02-24 | $8.57M derived: sum of 3 quarters · filed 2026-02-24 | $10.07M 10-K · filed 2026-02-24 |
| 2023-09-30 | $2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $2.07M derived: sum of 2 quarters · filed 2024-10-30 | $3.57M 10-Q · filed 2024-10-30 | $5.21M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $1.50M 10-Q · filed 2024-07-29 | $3.14M derived: sum of 3 quarters · filed 2025-02-26 | $4.39M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.50M 10-Q · filed 2024-05-01 | $3.14M derived: sum of 2 quarters · filed 2025-02-26 | $4.39M derived: sum of 3 quarters · filed 2025-02-26 | $5.38M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $2.89M derived: sum of 2 quarters · filed 2025-02-26 | $3.88M derived: sum of 3 quarters · filed 2025-02-26 | $3.43M 10-K · filed 2025-02-26 |
| 2022-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $2.24M derived: sum of 2 quarters · filed 2023-11-01 | $1.79M 10-Q · filed 2023-11-01 | $2.91M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $986.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $539.00K 10-Q · filed 2023-08-02 | $1.66M derived: sum of 3 quarters · filed 2024-02-15 | $544.00K derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | -$447.00K 10-Q · filed 2023-05-03 | $670.00K derived: sum of 2 quarters · filed 2024-02-15 | -$442.00K derived: sum of 3 quarters · filed 2024-02-15 | $4.98M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $5.00K derived: sum of 2 quarters · filed 2024-02-15 | $5.42M derived: sum of 3 quarters · filed 2024-02-15 | $1.43M 10-K · filed 2024-02-15 |
| 2021-09-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $4.31M derived: sum of 2 quarters · filed 2022-11-03 | $310.00K 10-Q · filed 2022-11-03 | $4.55M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $5.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.42M 10-Q · filed 2022-08-04 | $5.66M derived: sum of 3 quarters · filed 2023-02-28 | $4.89M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$4.00M 10-Q · filed 2022-05-05 | $243.00K derived: sum of 2 quarters · filed 2023-02-28 | -$525.00K derived: sum of 3 quarters · filed 2023-02-28 | -$4.48M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $3.47M derived: sum of 2 quarters · filed 2023-02-28 | -$486.00K derived: sum of 3 quarters · filed 2023-02-28 | $6.27M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$768.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$4.73M derived: sum of 2 quarters · filed 2021-11-03 | $2.03M 10-Q · filed 2021-11-03 | -$448.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$3.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $2.80M 10-Q · filed 2021-07-29 | $320.00K derived: sum of 3 quarters · filed 2022-02-15 | $2.95M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $6.76M 10-Q · filed 2021-05-06 | $4.28M derived: sum of 2 quarters · filed 2022-02-15 | $6.91M derived: sum of 3 quarters · filed 2022-02-15 | $7.47M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | -$2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $154.00K derived: sum of 2 quarters · filed 2022-02-15 | $710.00K derived: sum of 3 quarters · filed 2022-02-15 | $2.34M 10-K · filed 2022-02-15 |
| 2019-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $3.19M derived: sum of 2 quarters · filed 2020-11-03 | $4.82M 10-Q · filed 2020-11-03 | $3.04M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $556.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $2.19M 10-Q · filed 2020-08-04 | $414.00K derived: sum of 3 quarters · filed 2021-02-23 | -$8.93M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $1.63M 10-Q · filed 2020-05-04 | -$142.00K derived: sum of 2 quarters · filed 2021-02-23 | -$9.49M derived: sum of 3 quarters · filed 2021-02-23 | $1.96M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$11.12M derived: sum of 2 quarters · filed 2021-02-23 | $327.00K derived: sum of 3 quarters · filed 2021-02-23 | $2.29M 10-K · filed 2021-02-23 |
| 2018-09-30 | -$9.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.10M derived: sum of 2 quarters · filed 2019-11-07 | $4.06M 10-Q · filed 2019-11-07 | $7.49M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $11.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $13.40M 10-Q · filed 2019-08-01 | $16.83M derived: sum of 3 quarters · filed 2020-02-24 | $19.20M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $1.96M 10-Q · filed 2019-05-09 | $5.39M derived: sum of 2 quarters · filed 2020-02-24 | $7.76M derived: sum of 3 quarters · filed 2020-02-24 | $8.05M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $5.80M derived: sum of 2 quarters · filed 2020-02-24 | $6.09M derived: sum of 3 quarters · filed 2020-02-24 | $5.44M 10-K · filed 2020-02-24 |
| 2017-09-30 | $2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $2.66M derived: sum of 2 quarters · filed 2018-11-02 | $2.01M 10-Q · filed 2018-11-02 | $3.64M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$356.00K 10-Q · filed 2018-08-09 | $1.27M derived: sum of 3 quarters · filed 2019-02-26 | $203.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | -$646.00K 10-Q · filed 2018-05-09 | $978.00K derived: sum of 2 quarters · filed 2019-02-26 | -$87.00K derived: sum of 3 quarters · filed 2019-02-26 | $2.46M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $559.00K derived: sum of 2 quarters · filed 2019-02-26 | $3.11M derived: sum of 3 quarters · filed 2019-02-26 | $3.64M 10-K · filed 2019-02-26 |
| 2016-09-30 | -$1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $1.48M derived: sum of 2 quarters · filed 2017-11-03 | $2.02M 10-Q · filed 2017-11-03 | $2.29M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $2.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $3.08M 10-Q · filed 2017-08-02 | $3.36M derived: sum of 3 quarters · filed 2018-02-28 | $4.35M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $531.00K 10-Q · filed 2017-05-02 | $807.00K derived: sum of 2 quarters · filed 2018-02-28 | $1.80M derived: sum of 3 quarters · filed 2018-02-28 | $2.45M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $276.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $1.27M derived: sum of 2 quarters · filed 2018-02-28 | $1.92M derived: sum of 3 quarters · filed 2018-02-28 | $2.89M 10-K · filed 2018-02-28 |
| 2015-09-30 | $994.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $1.64M derived: sum of 2 quarters · filed 2016-11-02 | $2.61M 10-Q · filed 2016-11-02 | $3.20M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $650.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $1.62M 10-Q · filed 2016-08-03 | $2.21M derived: sum of 3 quarters · filed 2017-03-06 | $2.73M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $967.00K 10-Q · filed 2016-05-04 | $1.55M derived: sum of 2 quarters · filed 2017-03-06 | $2.08M derived: sum of 3 quarters · filed 2017-03-06 | $2.38M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $588.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $1.11M derived: sum of 2 quarters · filed 2017-03-06 | $1.41M derived: sum of 3 quarters · filed 2017-03-06 | $1.91M 10-K · filed 2017-03-06 |
| 2014-09-30 | $521.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $824.00K derived: sum of 2 quarters · filed 2015-11-06 | $1.32M 10-Q · filed 2015-11-06 | $1.73M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-06-30 | $303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $797.00K 10-Q · filed 2015-08-07 | $1.21M derived: sum of 3 quarters · filed 2016-03-10 | $1.37M derived: sum of 4 quarters · filed 2016-03-10 |
| 2014-03-31 | $494.00K 10-Q · filed 2015-05-08 | $903.00K derived: sum of 2 quarters · filed 2016-03-10 | $1.07M derived: sum of 3 quarters · filed 2016-03-10 | $779.00K derived: sum of 4 quarters · filed 2016-03-10 |
| 2013-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $573.00K derived: sum of 2 quarters · filed 2016-03-10 | $285.00K derived: sum of 3 quarters · filed 2016-03-10 | $871.00K 10-K · filed 2016-03-10 |
| 2013-09-30 | $164.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | -$124.00K derived: sum of 2 quarters · filed 2014-11-07 | $462.00K 10-Q · filed 2014-11-07 | $665.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | -$288.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $298.00K 10-Q · filed 2014-08-08 | $501.00K derived: sum of 3 quarters · filed 2015-03-13 | $500.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $586.00K 10-Q · filed 2014-05-12 | $789.00K derived: sum of 2 quarters · filed 2015-03-13 | $788.00K derived: sum of 3 quarters · filed 2015-03-13 | |
| 2012-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $202.00K derived: sum of 2 quarters · filed 2015-03-13 | $557.00K 10-K · filed 2015-03-13 | |
| 2012-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $354.00K 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | $355.00K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |